Modeling medulloblastoma in vivo and with human cerebellar organoids
Group 3 medulloblastoma (MB) is considered one of the most aggressive forms of this cancer. Here, the authors show that Otx2 and c-MYC oncogenes can drive Group 3 MB formation in mouse and human cerebellar organoids while SMARCA4 overexpression or a EZH2-specific inhibitor can inhibit tumorigenesis.
Guardado en:
Autores principales: | Claudio Ballabio, Marica Anderle, Matteo Gianesello, Chiara Lago, Evelina Miele, Marina Cardano, Giuseppe Aiello, Silvano Piazza, Davide Caron, Francesca Gianno, Andrea Ciolfi, Lucia Pedace, Angela Mastronuzzi, Marco Tartaglia, Franco Locatelli, Elisabetta Ferretti, Felice Giangaspero, Luca Tiberi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9519a8f838f84cd89a2a82dbc13a35e4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cerebellar Liponeurocytoma Mimicking Medulloblastoma: Case Report of a Childhood and Literature Review
por: Changhui Dong, et al.
Publicado: (2021) -
Cytotoxic effects and tolerability of gemcitabine and axitinib in a xenograft model for c-myc amplified medulloblastoma
por: Stefanie Schwinn, et al.
Publicado: (2021) -
The transcriptional landscape of Shh medulloblastoma
por: Patryk Skowron, et al.
Publicado: (2021) -
Wnt activation as a therapeutic strategy in medulloblastoma
por: Branavan Manoranjan, et al.
Publicado: (2020) -
CREB signaling activity correlates with differentiation and survival in medulloblastoma
por: Inna Armandari, et al.
Publicado: (2021)